This is a community-generated profile. If you would like to claim it, please .
Elixir Pharmaceuticals Funding
$58M
22 rounds
Elixir Pharmaceuticals is active in the following markets / industries: biotechnology, pharmaceuticals and diabetes. The company has secured funding across 2 rounds, totaling in an amount of $58M. Their most recent funding was raised on May 27, 2009.
Investors of Elixir Pharmaceuticals
Hercules Capital
Inc.
YFY Biotech Management Company
Omega Funds
MPM Capital
Rounds
D
C
Oxford Bioscience Partners
Rounds
D
C
ARCH Venture Partners
Rounds
D
C
Alpha Omega Funds
Rounds
D
CDIB BioScience Ventures
Rounds
C
